Baricitinib provides greater improvements in patient-reported outcomes across all disease activity levels compared to placebo and adalimumab in rheumatoid arthritis
| मुख्य लेखकों: | , , , , , , , |
|---|---|
| स्वरूप: | Conference item |
| भाषा: | English |
| प्रकाशित: |
BMJ Publishing Group
2021
|
| _version_ | 1826306385023860736 |
|---|---|
| author | Taylor, P Blanco, R Ikeda, K Jia, B Chen, YF Walls, C Haladyj, E Fautrel, B |
| author_facet | Taylor, P Blanco, R Ikeda, K Jia, B Chen, YF Walls, C Haladyj, E Fautrel, B |
| author_sort | Taylor, P |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T06:47:09Z |
| format | Conference item |
| id | oxford-uuid:fb40df96-b10c-434e-b699-e729e1f3eda6 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:47:09Z |
| publishDate | 2021 |
| publisher | BMJ Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:fb40df96-b10c-434e-b699-e729e1f3eda62022-03-27T13:12:19ZBaricitinib provides greater improvements in patient-reported outcomes across all disease activity levels compared to placebo and adalimumab in rheumatoid arthritisConference itemhttp://purl.org/coar/resource_type/c_6670uuid:fb40df96-b10c-434e-b699-e729e1f3eda6EnglishSymplectic ElementsBMJ Publishing Group2021Taylor, PBlanco, RIkeda, KJia, BChen, YFWalls, CHaladyj, EFautrel, B |
| spellingShingle | Taylor, P Blanco, R Ikeda, K Jia, B Chen, YF Walls, C Haladyj, E Fautrel, B Baricitinib provides greater improvements in patient-reported outcomes across all disease activity levels compared to placebo and adalimumab in rheumatoid arthritis |
| title | Baricitinib provides greater improvements in patient-reported outcomes across all disease activity levels compared to placebo and adalimumab in rheumatoid arthritis |
| title_full | Baricitinib provides greater improvements in patient-reported outcomes across all disease activity levels compared to placebo and adalimumab in rheumatoid arthritis |
| title_fullStr | Baricitinib provides greater improvements in patient-reported outcomes across all disease activity levels compared to placebo and adalimumab in rheumatoid arthritis |
| title_full_unstemmed | Baricitinib provides greater improvements in patient-reported outcomes across all disease activity levels compared to placebo and adalimumab in rheumatoid arthritis |
| title_short | Baricitinib provides greater improvements in patient-reported outcomes across all disease activity levels compared to placebo and adalimumab in rheumatoid arthritis |
| title_sort | baricitinib provides greater improvements in patient reported outcomes across all disease activity levels compared to placebo and adalimumab in rheumatoid arthritis |
| work_keys_str_mv | AT taylorp baricitinibprovidesgreaterimprovementsinpatientreportedoutcomesacrossalldiseaseactivitylevelscomparedtoplaceboandadalimumabinrheumatoidarthritis AT blancor baricitinibprovidesgreaterimprovementsinpatientreportedoutcomesacrossalldiseaseactivitylevelscomparedtoplaceboandadalimumabinrheumatoidarthritis AT ikedak baricitinibprovidesgreaterimprovementsinpatientreportedoutcomesacrossalldiseaseactivitylevelscomparedtoplaceboandadalimumabinrheumatoidarthritis AT jiab baricitinibprovidesgreaterimprovementsinpatientreportedoutcomesacrossalldiseaseactivitylevelscomparedtoplaceboandadalimumabinrheumatoidarthritis AT chenyf baricitinibprovidesgreaterimprovementsinpatientreportedoutcomesacrossalldiseaseactivitylevelscomparedtoplaceboandadalimumabinrheumatoidarthritis AT wallsc baricitinibprovidesgreaterimprovementsinpatientreportedoutcomesacrossalldiseaseactivitylevelscomparedtoplaceboandadalimumabinrheumatoidarthritis AT haladyje baricitinibprovidesgreaterimprovementsinpatientreportedoutcomesacrossalldiseaseactivitylevelscomparedtoplaceboandadalimumabinrheumatoidarthritis AT fautrelb baricitinibprovidesgreaterimprovementsinpatientreportedoutcomesacrossalldiseaseactivitylevelscomparedtoplaceboandadalimumabinrheumatoidarthritis |